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The physiologic stress induced by physical activity is reflected in immune system perturbations, oxidative stress, muscle injury, and
inflammation. We investigated the effect of astaxanthin (Asx) supplementation on salivary IgA (sIgA) and oxidative stress status
in plasma, along with changes in biochemical parameters and total/differential white cell counts. Forty trained male soccer players
were randomly assigned to Asx and placebo groups. Asx group was supplemented with 4mg of Asx. Saliva and blood samples
were collected at the baseline and after 90 days of supplementation in preexercise conditions. We observed a rise of sIgA levels at
rest after 90 days of Asx supplementation, which was accompanied with a decrease in prooxidant-antioxidant balance. The plasma
muscle enzymes levels were reduced significantly by Asx supplementation and by regular training.The increase in neutrophil count
and hs-CRP level was found only in placebo group, indicating a significant blunting of the systemic inflammatory response in the
subjects taking Asx. This study indicates that Asx supplementation improves sIgA response and attenuates muscle damage, thus
preventing inflammation induced by rigorous physical training. Our findings also point that Asx could show significant physiologic
modulation in individuals withmucosal immunity impairment or under conditions of increased oxidative stress and inflammation.
1. Introduction
Astaxanthin (Asx) is a red-orange carotenoid mainly pro-
duced by micro- and macroalgal species and accumulated
in many marine organisms, such as shrimps, crabs, trout,
and salmon. The polyene system gives astaxanthin its dis-
tinctive molecular structure, chemical properties, and light-
absorption characteristics [1]. The presence of the hydroxyl
and keto moieties on each ionone ring explains some of its
unique features such as higher antioxidant (AO) activity, a
more polar nature than other carotenoids, and ability to be
esterified [2]. Its both high AO potency and polar prop-
erties, make Asx an attractive nutraceutical for promising
applications in human health and nutrition. Asx has also
been attributed with extraordinary potential for protecting
the organism against a wide range of diseases [3].
The mucosal immune system functions as the first line
of defense against pathogen invasion by preventing the
attachments of infectious agents to mucosal surfaces [4]. An
important activity of the epithelia lining in gastrointestinal,
respiratory, and genitourinary tract is the production of
secretory IgA (sIgA), the antibody that largely dominates
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mucosal humoral immunity [5]. sIgA protects mucosal
surfaces by directly cross-linking environmental microor-
ganisms or macromolecules, thus preventing their contact
with the surface of epithelial cells and hence facilitating
their elimination [6]. Numerous studies of saliva compo-
sition have found a decreased sIgA secretion with age [7],
psychological, and occupational stresses [8] and also in
nutritional deficiencies [9]. In addition, mounting evidence
indicates that prolonged and intensive physical exertion can
cause a decrease in sIgA concentration and secretion rate
[10]. Lowered concentrations of sIgA are associated with
an increased frequency of upper respiratory tract infection
(URTI) episodes or with reduced protection against certain
infections [11].
Intensive and sustained physical activity elevates the
generation of free radicals and reactive oxygen species (ROS),
thus creating an imbalance between ROS and antioxidants
and leading to oxidative stress that not only causes lipid
peroxidation and protein oxidation but also may have a
negative impact on immune function [12]. Asx possesses
antioxidant, free radical scavenging, and anti-inflammatory
properties that may affect human immune system and
resistance to pathogens, although most data come from in
vitro and animal studies [13]. These studies showed that Asx
stimulated a delayed-type hypersensitivity (DTH) response,
the natural killer (NK) cells cytotoxic activity, and increased
concentrations of IgG and IgM and B cell population [14–17].
No published human studies exist regarding the influence
of Asx ingestion on exercise-inducedmucosal immunity dys-
function. One human study showed that Asx could enhance
immune response and decrease a DNA oxidative damage and
inflammation in healthy females [18]. Therefore, the purpose
of the present investigation was to test the hypothesis that
Asx supplementation is effective in enhancing sIgA secretion
in young soccer players. Compared with previous research
in this field, particular strength of this study is the fact it
was conducted during a regular competitive season, reflecting
habitual conditions of nutrition and training program. In
addition, we determined oxidative status parameters, along
with biochemical and hematological profile, in order to
examine possible connections among mucosal immunity,
oxidative stress, inflammation, and Asx supplementation in
young, healthy athletes.
2. Material and Methods
2.1. Subjects. Forty trainedmale soccer players, among young
selection of soccer club “Partizan,” Belgrade, were recruited
as experimental subjects. The participants met the following
exclusion criteria: smokers, subjects with recurrent respira-
tory infections, subjects taking antibiotics, subjects taking
immunosuppressive drugs, and alcohol abuse. Athletes as
well as their parents gave the written consent after having
been explained the purpose, demands, and possible risks
associatedwith the study.The studywas conducted according
to the guidelines laid down inDeclaration of Helsinki. Exper-
imental procedures were approved by the Ethical Committee
of Sports Medicine Association of Serbia.They were involved
in a controlled training program during a 90-day period over
competitive season, in which they had 5 to 7 training sessions
per weekwith an average weekly training of 10 to 15 hours and
took participation in national championship. They also had
different aspects of trainings, including strength, resistance,
cardio, flexibility, and proprioceptive training.
2.2. Research Design and Supplementation. Soccer players
were randomly assigned to Asx (𝑁 = 21) or placebo (P,𝑁 =
19) groups.Under double-blind procedures, subjects received
Asx (4mg per day) or placebo supplements for 90 days. The
Asx used in this study was a homogenized and spray dried
biomass of the green unicellular algaHaematococcus pluvialis.
Both Asx and placebo capsules weremanufactured by Bioreal
(Sweden) and generously donated by Oriflame, Serbia. The
dietary supplementation comprised of one capsule daily
taken orally in conjunction with a meal.
Two weeks before the first test session, subjects reported
to the laboratory for orientation, measurement of body
composition, and cardiorespiratory fitness. Body weight and
total body fat were measured using the BC-418, 8-contact
electrode device (Tanita, Tokyo, Japan), which uses bioelec-
trical impedance analysis for body composition analysis.
Heightwasmeasured to the nearest 0.1 cmwith a portable sta-
diometer. Body mass index (BMI) was calculated by dividing
the weight in kilograms by the square of the height in meters
(kg/m2). VO2max was measured on a motor driven treadmill
(Run race, Techno gym, Italy), using an indirect calorimetry
system (Quark b2, Cosmed, Italy) during an incremental
exercise test to volitional fatigue. Basic demographic and
training datawere obtained through a questionnaire. Subjects
were instructed to restrain themselves from making any
drastic changes in the diet. They agreed to avoid the use
of vitamin/mineral supplements, antioxidant supplements,
nutritional supplements, ergogenic aids, herbs, and medica-
tions known for their effect on immune function, 1 month
before and during the study. Subjects recorded food intake in
a 4-day food record before the first exercise test session. The
food records were analyzed using CRON-O-Meter v0.9.6.
software.
Saliva and blood samples were collected at the onset of
the study and after 90 days of supplementation, between 9:00
and 10:00 a.m., after overnight fast, before training session.
For all collection points, players were restrained from water
consumption 10min before sampling. The training sessions
were carried out under the same conditions, in the same place
and at the same time of the day to avoid circadian variations.
Each subject served as self-control to eliminate any biological
variability in the response to Asx supplementation.
2.3. Salivary Flow Measurement. Whole unstimulated saliva
was collected using salivettes (Sersted, Vumbrecht, Ger-
many), by placing the cotton swabunder the tongue.All saliva
collections (2min, electronically timed) were made after
players had been sitting quietly for a few minutes, leaning
forward, with their heads tilted. Immediately after collection,
the obtained saliva samples were separated from the cotton by
centrifuging at 1500×g for 15 minutes. The supernatant fluid
was frozen at −80∘C for later analysis of sIgA. Before and after
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saliva collection, salivettes were weighted on an analytical
balance. The amount of saliva in grams was converted to
milliliters assuming that the specific gravity of saliva is 1 and
divided by 2 to express salivary flow in mL/min.
2.4. Measurement of sIgA Concentration and Secretion Rate.
The sIgA concentration was measured by enzyme-linked
immunosorbent assay (ELISA). Briefly, the test was per-
formed on 96-well microtiter plates, which were coated with
goat anti-human IgA (1 : 100 dilution, AbD Serotec, Oxford,
UK) in coating buffer (0.1M carbonate-bicarbonate, pH 9.5)
and kept overnight at 4∘C. On the day of analysis, plates
were incubated for 60min at room temperature before being
washed with TTBS buffer (Tween 20 Tris Buffered saline,
pH 7.5) and then blocked with 3% gelatin in TTBS for
2 h at room temperature. Samples were thawed and then
diluted (1 : 200) with a sample diluent (1% gelatin in TTBS).
Known concentrations of human secretory IgA (AbDSerotec,
Oxford, UK) and controls were used to construct a standard
curve. The plate was then washed before standards and
samples were added to wells (in duplicate) and incubated for
1 h at room temperature. The plate was washed again before
addition of diluted goat anti-human horseradish peroxidase
conjugates (AbD Serotec, Oxford, UK). After incubation, the
plate was washed again before addition of substrate tetram-
ethylbenzidine (AbD Serotec, Oxford, UK) and incubated for
30min in the dark. The colorimetric reaction was stopped
via addition of 100 𝜇L of sulfuric acid, and the absorbance
of solution in each well was determined at 450 nm by using
ELx800 Absorbance Microplate Reader (Biotek, Winooski,
USA). Regression analysis using the relation of standard sIgA
concentrations and amount of absorbance (nm) was used to
interpolate the concentration of sIgA in the samples. sIgA is
expressed as absolute concentration and secretion rate. sIgA
secretion rate (𝜇g/min) was determined by multiplying the
absolute sIgA concentration (𝜇g/mL) with saliva flow rate
(mL/min).
2.5. Oxidative Stress Status. For determination of oxidative
status parameters, the venous blood was collected into
heparin evacuated tube (Greiner Bio-one, Kremsmu¨nster,
Austria). The blood samples were centrifuged at 1500 g for
10min, and aliquots of plasma were stored at −80∘C for later
analysis.
Total antioxidant status (TAS) was determined using an
automated method developed by Erel [19]. A standardized
solution of Fe2+–o-dianisidine complex reacts with a stan-
dardized solution ofH
2
O
2
by a Fenton-type reaction, produc-
ing hydroxyl radicals (OH∙). These potent ROS oxidize the
reduced colorless o-dianisidine molecules to yellow-brown
colored dianisidyl radicals at low pH. Antioxidants in the
sample suppress the oxidation reactions and color formation.
This reaction can be monitored by spectrophotometry. The
reaction rate is calibrated with Trolox (a water-soluble ana-
logue of vitamin E, 6-hydroxy-2,5,7,8-tetramethylchroman-
2-carboxylic acid) and was incorporated into Ilab 300 plus
autoanalyser (Instrumentation Laboratory, Milan, Italy). The
TAS value of the samples tested is expressed as mmolTrolox
equiv./L.
Total oxidant status (TOS) was determined according to
Erels’ method [20]. This assay is based on the oxidation of
ferrous ion to ferric ion in the presence of various oxidant
species in serum. The ferric ion makes a colored complex
with xylenol orange in an acidic medium.The color intensity,
which can be measured spectrophotometrically, is related
to the total amount of oxidant molecules present in the
sample.The assaywas calibratedwithH
2
O
2
and incorporated
into Ilab 300 plus autoanalyser (Instrumentation Laboratory,
Milan, Italy). The results are expressed in terms of micro-
molar hydrogen peroxide equivalent per liter (𝜇molH
2
O
2
equiv./L).
Prooxidant-antioxidant balance (PAB) was measured
according to a previously published method [21]. This
method is based on two different oxidation-reduction reac-
tions which take place simultaneously. In enzymatic reaction,
the chromogen TMB is oxidized to a colored cation by perox-
ides, and in the chemical reaction, the colored TMB cation is
reduced to a colorless compound by antioxidants. The pho-
tometric absorbance is then compared with the absorbance
given by a series of standard solutions that are made by
mixing varying proportions (0–100%) of 250mmol/L H
2
O
2
,
as a representative of hydroperoxides, which is an indicator of
total oxidant status, with 3mmol/L uric acid (in 10mmol/L
NaOH), as a representative of the antioxidant capacity. This
photometric comparison was carried out using an ELISA
reader.
TMB powder (60mg) was dissolved in 10mL of DMSO.
For preparation of TMB cation, 400 𝜇L of TMB/DMSO was
added in 20mL of acetate buffer (0.05M, pH 4.5), and then
70 𝜇L of fresh chloramine T (100mM) solution in distilled
water was added. The mixture was incubated in a dark
place for 2 hr at room temperature, after which 25 units of
peroxidase enzyme solution were added into 20mL TMB
cation, dispensed in 1mL, and put at −20∘C. To prepare
the TMB solution, 200𝜇L of TMB/DMSO was added into
10mLof acetate buffer (0.05M, pH5.8).Theworking solution
was prepared by mixing 1mL of TMB cation with 10mL of
TMB solution. The mixture was incubated for 2min at room
temperature, in a dark place, and it was used immediately.
The sample (10 𝜇L), standard, or blank (distilled water) were
mixed with 200𝜇L of working solution, in each well of a
96-well plate, which was then incubated in a dark place
at 37∘C for 12min. At the end of incubation time, 100 𝜇L
of 2N HCl was added into each well and measured in
ELISA reader at 450 nm, with a reference wavelength of 620
or 570 nm (ELx800 Absorbance Microplate Reader, Biotek,
Winooski, USA). A standard curve was provided from the
values relative to the standard samples.The PAB values of the
unknown samples were calculated using the standard curve
and expressed in arbitrary HK units, which represent the
percentage of H
2
O
2
in standard solution, multiplied by 6.
2.6.Hematological andBiochemical Parameters. Hematologi-
cal analysiswas performed in the blood samples collected into
K-EDTA tubes (Greiner Bio-one, Kremsmu¨nster, Austria),
using an automated hematology analyzer Cell-Dyn 3700
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(Abbott Diagnostics, Illinois, USA). To examine biochemical
parameters, blood samples were drawn from an antecubital
vein into sample tube with serum separator gel (Greiner
Bio-one, Kremsmu¨nster, Austria) and then left to coagulate
for 30min to separate the serum, and the obtained sam-
ples were stored at −80∘C for later analysis. The following
items were included in the general biochemical examination:
aspartate aminotransferase (AST), alanine aminotransferase
(ALT), creatine kinase (CK), lactate dehydrogenase (LDH),
uric acid (UA), creatinine (Cre), high sensitivity C-reactive
protein (hs-CRP), total cholesterol (CHOL), HDL cholesterol
(HDL-C), and triglycerides (TG). Biochemical analysis was
performed using an ILab 300 Plus autoanalyser (Instrumen-
tation Laboratory, Milan, Italy) employing commercial kits
(Bioanalytica, Belgrade, Serbia). The concentration of LDL
cholesterol (LDL-C) was calculated using the formula of
Friedewald et al. [22].
2.7. Statistical Analysis. Statistical analyses were performed
using the PASW Statistics version 18.0 and MedCalc (version
11.4 Software, Belgium) software. All data were assessed
for normality (Kolmogorov-Smirnov tests). The results are
expressed in terms ofmean values and standard error (SE) for
normally distributed variables. Where distribution differed
from a normal distribution, geometric means and 95% confi-
dence intervals were given. Subjects’ baseline characteristics
and nutritional parameters between treatment groups were
compared using independent-sample t-test. The effects of
supplementation and training were analyzed by two-way
analysis of variance (ANOVA) with repeated measures to
test for the two main effects and for the interaction between
them. When a significant 𝑝 value was obtained, Bonferroni
post hoc comparison test was employed to determine the
differences between groups. Two-tailed 𝑝 values are given
throughout. Due to the fact that the distributions of sIgA
absolute concentrations and secretion rate, AST, ALT, CK,
and hs-CRP were skewed, logarithmic transformation of
these values was performed before statistical comparisons
were made.
3. Results
3.1. Subjects Characteristics. Physical characteristics for the
40 soccer players randomized to Asx and P groups are
summarized in Table 1. No significant differences were found
between groups according to age, body composition, or
VO2max (𝑝 > 0.05, t-test).
According to 4-day food records analysis using CRON-
O-Meter v0.9.6 software, estimated daily energy and nutrient
intake in two experimental groups were similar (𝑝 > 0.05),
Table 2.
3.2. Salivary Flow, sIgA Absolute Concentration, and Secretion
Rate. Salivary flow measurement was unaffected by training
or supplementation (𝑝 > 0.05). The obtained values were
unchanged after 90 days of training and supplementation
(Figure 1(a)).
ANOVA repeated measures showed a significant inter-
action effect of supplementation and training (𝐹 = 6.221,
Table 1: Subject characteristics at baseline.
Astaxanthin Placebo
Age (year) 17.9 ± 0.2 17.6 ± 0.1
Weight (kg) 71 ± 1.7 72 ± 1.8
Height (cm) 178 ± 1.4 180 ± 1.4
Body mass index (kg/m2) 22.4 ± 0.3 22.2 ± 0.4
Fat (%) 9.4 ± 0.7 9.7 ± 0.8
VO2max (mL/min/kg) 55.5 ± 1.2 52.9 ± 0.7
Values are expressed as mean ± SE.
Table 2: Estimated daily energy and nutrient intake of soccer
players.
Asx P
Energy (kcal) 3154 ± 247 2932 ± 147
Protein (g) 124 ± 8.7 125 ± 6.3
Carbohydrates (g) 412 ± 33 366 ± 23
Monosaccharides (g) 109 ± 12 123 ± 18
Fiber (g) 13.2 ± 1.4 12.6 ± 1.5
Fat (g) 104 ± 9 101 ± 7
Saturated fat (g) 33.2 ± 3.5 29.9 ± 3.2
Cholesterol (mg) 328 ± 23 344 ± 38
Vitamin A (IU) 2312 ± 442 2120 ± 389
Vitamin C (mg) 149 ± 25 135 ± 30
Vitamin E (mg) 5.4 ± 0.7 6.1 ± 1.5
Copper (mg) 2.3 ± 0.4 1.92 ± 0.5
Iron (mg) 14.4 ± 0.9 15.1 ± 1.6
Manganese (mg) 4.9 ± 0.3 4.0 ± 0.9
Selenium (𝜇g) 187 ± 15 164 ± 8
Zinc (mg) 13.0 ± 1.4 13.5 ± 1.8
Values are expressed as mean ± SE.
𝑝 < 0.05) on sIgA absolute concentration as well as on sIgA
secretion rate (𝐹 = 4.608, 𝑝 < 0.05) (Figures 1(b) and 1(c)).
Post hoc comparison revealed a significant increase of sIgA
absolute concentration and secretion rate in supplemented
group after 90 days when compared to baseline values (𝑝 <
0.05), while there were no significant changes in P group.
3.3. Oxidative Stress Status. Oxidative stress status is reported
in Table 3. Regular soccer training had a significant effect on
TOS, regardless of supplementation (main effect of training,
𝐹 = 108.678, 𝑝 < 0.001). TOS decreased in both, the
supplemented and the P group, after 90 days of regular
training in comparison to baseline values. Basal TAS was
unaffected by soccer training and supplementation (𝑝 >
0.05). There was a significant decrease in PAB in Asx group
after 90 days in comparison to baseline values (interaction
effect of supplementation and training: 𝐹 = 25.371, 𝑝 < 0.05;
main effect of training: 𝐹 = 4.205, 𝑝 < 0.001), as a result
of continuous training and supplementation. No significant
changes were found in P group.
3.4. Hematological Parameters. After 90 days of training
and supplementation, ANOVA analysis showed a significant
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Figure 1: Salivary flow (a), salivary IgA concentration (b), and salivary IgA secretion rate (c) in soccer players at baseline and after 90 days
of supplementation. Values are presented as mean ± SE. The difference in relation to baseline was significant at 0.05 (∗).
Table 3: Oxidative stress status of the soccer players at baseline and after 90 days of supplementation.
Astaxanthin Placebo ANOVA
Before supplementation After supplementation Before supplementation After supplementation T S T × S
TAS (mmolTrolox
equiv./L) 0.551 ± 0.036 0.538 ± 0.029 0.532 ± 0.039 0.585 ± 0.031 ns ns ns
TOS (mmol/L) 15.4 ± 1.5 5.0 ± 0.5∗∗∗ 16.8 ± 1.6 5.1 ± 0.5∗∗∗ <0.001 ns ns
PAB (HK U) 479.1 ± 45.4 291.5 ± 33.3∗∗∗ 338.9 ± 48.8 258.9 ± 35.8 <0.001 ns <0.05
Values are expressed as mean ± SE. ANOVA: T-training, S-supplementation, and T × S-training and supplementation interaction effect.
The difference in relation to baseline was significant at 𝑝 < 0.001 (∗∗∗).
increase in leukocyte count in P group (interaction effect
of supplementation and training: 𝐹 = 4.528, 𝑝 < 0.05;
main effect of training: 𝐹 = 3.989, 𝑝 < 0.05) but not in
Asx group, as presented in Figure 2. There was a significant
increase in neutrophil count in P group after 90 days of obser-
vational period compared to baseline values (main effect of
training: 𝐹 = 4.875, 𝑝 < 0.01). These changes were not
detected in supplemented group.
3.5. Biochemical Parameters. Biochemical parameters are
shown in Table 4. ANOVA revealed a significant main effect
of training on AST (𝐹 = 57.029, 𝑝 < 0.001), CK (𝐹 = 29.000,
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Table 4: Biochemical profile of the soccer players at baseline and after 90 days of supplementation.
Astaxanthin Placebo ANOVA
Before supplementation After supplementation Before supplementation After supplementation T S T × S
AST (U/L)† 37.5 (29.2–48.1) 23.8 (20.1–28.1)∗∗∗ 41.0 (35.7–47.0) 28.7 (24.5–33.6)∗∗ 0.001 <0.05 ns
ALT (U/L)† 21.1 (16.8–25.6) 18.9 (15.6–21.6) 20.7 (18.6–22.5) 19.2 (16.1–22.6) ns ns ns
CK (U/L)† 448 (330–608) 248 (172–360)∗∗ 525 (283–974) 367 (244–552) <0.01 ns ns
LDH (U/L)‡ 418.3 ± 13.8 303.5 ± 10.3∗∗ 441.2 ± 17.5 359.4 ± 15.8∗ <0.001 <0.05 ns
UA (𝜇mol/L)† 330.3 ± 19.1 300.4 ± 14.0 346.5 ± 20.9 315.9 ± 15.5 <0.05 ns ns
Cre (𝜇mol/L)† 129.6 ± 2.1 126.5 ± 2.2 133.1 ± 2.3 130.5 ± 2.4 <0.05 ns ns
hs-CRP (mg/L)† 1.35 (1.00–1.82) 1.19 (0.89–1.59) 1.26 (0.89–1.78) 1.98 (1.24–3.17) ns ns 0.05
CHOL (mmol/L)‡ 4.28 ± 0.20 4.39 ± 0.24 4.54 ± 0.28 4.50 ± 0.27 ns ns ns
HDL-C (mmol/L)‡ 1.27 ± 0.19 1.30 ± 0.05 1.29 ± 0.07 1.31 ± 0.06 ns ns ns
LDL-C (mmol/L)‡ 2.63 ± 0.19 2.73 ± 0.20 2.97 ± 0.24 2.91 ± 0.25 ns ns ns
TG (mmol/L)‡ 0.84 ± 0.12 0.80 ± 0.08 0.95 ± 0.14 0.70 ± 0.09 ns ns ns
‡Mean± SE.; †Geometricmean values (95th confidence interval). ANOVA: T-training, S-supplementation, andT× S-training and supplementation interaction
effect. The difference in relation to baseline was significant at 𝑝 < 0.05 (∗), 𝑝 < 0.01 (∗∗), and 𝑝 < 0.001 (∗∗∗).
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Figure 2: Total leukocyte count (denoted by numbers at the top of
the bars); neutrophil, lymphocyte, and monocyte counts in soccer
players at baseline and after 90 days of supplementation.
𝑝 < 0.01), and LDH (𝐹 = 87.641, 𝑝 < 0.001) plasma
levels. Post hoc comparison showed a significant decrease in
CK activity in Asx group after 90 days compared to baseline
values (𝑝 < 0.01), while a decrease in P group was not
statistically significant. After 90 days of continuous training,
AST and LDHdecreased significantly in bothAsx (𝑝 < 0.001,
𝑝 < 0.01, resp.) and P group (𝑝 < 0.01, 𝑝 < 0.5, resp.).
In addition, a significant main effect of supplementation was
observed on AST (𝐹 = 3.979, 𝑝 < 0.05) and LDH (𝐹 = 3.995,
𝑝 < 0.05) levels, with lower activity in Asx compared to P
group.
UA and Cre levels significantly decreased in both groups
after 90 days of observational period (UA main effect of
training, 𝐹 = 5.528, 𝑝 < 0.05; Cre main effect of training, 𝐹 =
4.429, 𝑝 < 0.05). ANOVA analysis also showed a significant
supplementation and training interaction effect (𝐹 = 4.050,
𝑝 = 0.05) on hs-CRP levels. Namely, after 90 days of regular
soccer training, a 57% increase in hs-CRP levels may be
observed in P group, but not in the Asx group. Analysis of
lipid profile revealed no effect of training, supplementation,
or supplementation and training interaction.
4. Discussion
The main finding of the present study was the rise of sIgA
levels at rest after 90 days of Asx supplementation which
was accompanied with a decrease in prooxidant-antioxidant
balance (PAB). Also, the increase in neutrophil count and
hs-CRP level recorded in placebo group was not apparent in
supplemented group, indicating a significant blunting of the
systemic inflammatory response in the subjects taking Asx.
The observed increase in sIgA levels after supplemen-
tation could indicate the effect of Asx on sIgA synthesis.
Previous studies reported modulatory actions of Asx on
humoral immune response such as induced production of
polyclonal antibodies G and M in murine spleen cells [14],
increased IgG and IgM production in cats and dogs [16, 17],
partially restored humoral immune response in oldmice [23],
and enhanced immunoglobulin production in response to T-
dependent stimuli in human blood cells [15]. Although the
mechanism of Asx action was not known, it was suggested
that it enhanced the antibody production through release of
IL-1𝛼 [14], which is one of major regulating factors in B cell
differentiation [24]. The beneficial effect of Asx on mucosal
immunity, also found in our study, might be explained by its
antioxidant activity [25]. Immune cells are particularly sensi-
tive to oxidative stress due to a high percentage of polyun-
saturated fatty acids in their plasma membranes, and they
generally produce more oxidative products. Overproduction
of ROS can tip the oxidant/antioxidant balance, resulting in
destruction of cell membranes, proteins, and DNA [13]. ROS
overproduction during physical activity might also inhibit
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locomotor and bactericidal activity of neutrophils, as shown
in study of [26], where NK cell cytotoxic activity reduced
the proliferation of T- and B-lymphocytes and promoted
lymphocyte apoptosis.
Therefore, under conditions of increased oxidative stress
(e.g., during disease states or physical activity), dietary
antioxidants become critical in maintaining a desirable oxi-
dant/antioxidant balance [27]. In our study, oxidative stress
(measured by TOS) was significantly reduced after 90 days
of regular training in both groups of soccer players, probably
due to an upregulation in the body’s enzymatic AO defense
system. However, nonenzymatic antioxidants presented in
plasma (measured by TAS) were not affected by training or
supplementation during the observational period, which is
in accordance with previous studies [28, 29]. Antioxidants
are known to work synergistically to defend against oxidant
production. In other words, when one AO nutrient is lacking
in particular period of time, another could substitute it or it
may be regenerated by another that is in abundance [30].This
may be the reason why no changes in TAS levels at rest were
observed during 90 days of regular training and supplemen-
tation. Mobilization of tissue antioxidants into the plasma
in order to maintain the AO status and to protect the body
against ROS may also explain, in part, why no significant
changes in TAS levels at rest were observed in response to
training or Asx supplementation [31]. These results suggest
that human organism has very potent mechanisms which
protect cells against free radicals and oxidative stress.
However, we showed that Asx supplementation resulted
in decreased prooxidant-antioxidant balance (PAB) during
regular competitive season in young soccer players. There-
fore, we believe that deleterious effects caused by the excess
of ROS produced during physical activity can be additionally
attenuated by the Asx. Asx induced a better redox balance
favoring all cellular functions which depend on adequate
amounts of ROS, thereby supporting the mucosal immune
system. Our finding is in accordance with the study of Park
et al. [18] who examined the possible immune-enhancing,
AO, and anti-inflammatory activity of Asx in healthy women
and showed that Asx could decrease aDNAoxidative damage
and inflammation and enhance immune response.
The magnitude of muscle damage, evaluated by CK and
LDH in our study, was reduced significantly over the obser-
vational period, probably by adaptation and conditioning of
the muscle through regular training, as shown previously
by Powers and Jackson [32]. Asx supplementation addition-
ally attenuated exercise-induced muscle damage. Although
muscle damage represents a direct consequence of exercise
injury which mechanically disrupts muscle myofibrils, tissue
damage associated to exercise-induced free radical produc-
tion and subsequent oxidative stress was also suggested by
Davies et al. [33]. It can be hypothesized that Asx protects the
cell membranes against free radicals generated during heavy
exercise, thus preserving the functionality ofmuscle cells.The
unsaturated polygene chain of Asx could trap radicals in the
membrane, while the terminal rings scavenge radicals both at
the surface and in the interior of the phospholipid membrane
[34]. Similar results were obtained in animal experiments,
reporting that Asx attenuated oxidative damage of lipids and
DNA in gastrocnemius and heart as well as the leakage of CK
into plasma [35].
In this study, regular soccer training during the compet-
itive season led to certain changes in leukocytes count only
in placebo group. Over the time, total leukocytes count, neu-
trophil count, and hs-CRP levels had increased.The observed
elevation in hs-CRP due to the regular intensive training was
similar to the levels that have been associated with increased
risk of coronary vascular disease [36]. These changes were
not detected in supplemented group, which further supports
the notion that Asx, as dietary supplement, has the ability
to suppress minor inflammatory events induced by training.
Anti-inflammatory action of Asx was previously detected in
human and animal studies [16, 17, 35].
Evidence suggests that Asx has potential health-
promoting effects in prevention and treatment of various
diseases, such as chronic inflammatory diseases, metabolic
syndrome, diabetes, cardiovascular disease, neurodegenera-
tive diseases, exercise-induced fatigue, or male infertility
[13], which likely involves AO mechanisms and decreased
production of inflammatory mediators and cytokines. It is
already known that physiologic stress, induced by prolonged
and intensive physical activity, is reflected by transient,
yet significant immune system perturbations, along with
oxidative stress, muscle injury, and inflammation.
5. Conclusions
According to the results presented in this study, Asx supple-
mentation improved sIgA response and attenuated muscle
damage, probably due to restoring redox balance, thus pre-
venting inflammation induced by rigorous physical training.
Although our study focused on narrow population regarding
the age, gender, and life style, nevertheless, it showed the
modulating effects of Asx on the examined parameters.
Our findings also indicate that Asx could show significant
physiologic modulation in other individuals with mucosal
immunity impairment or under conditions of increased
oxidative stress and inflammation. Although the currently
available data and recent findings are very encouraging, more
extensive, well-controlled clinical trials are suggested for
other threatened categories.
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